Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.21
+0.06 (0.54%)
At close: Mar 20, 2026, 4:00 PM EDT
11.43
+0.22 (1.96%)
After-hours: Mar 20, 2026, 7:42 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $883.33 million as of March 20, 2026. Its market cap has increased by 115.00% in one year.
Market Cap
883.33M
Enterprise Value
1.34B
1-Year Change
115.00%
Ranking
Category
Stock Price
$11.21
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $883.33M, an increase of 67.58%. That is a compound annual growth rate of 8.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 883.33M | -25.15% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 927.45M |
| Valneva SE | 894.82M |
| Fortrea Holdings | 891.06M |
| Inhibrx Biosciences | 889.86M |
| Xencor | 889.60M |
| GH Research | 866.55M |
| SpyGlass Pharma | 866.25M |
| KalVista Pharmaceuticals | 859.29M |